2022 新蛋白发酵行业报告：发酵技术驱动中国未来食品发展
Driving the Future of Alternative Proteins: China Fermentation Industry Report (2022)
谷孚 GFIC 于 6 月 21 日发布《2022 新蛋白发酵行业报告》，这是国内首份聚焦发酵技术应用于新蛋白产业的报告，后续还将于 8 月举办线上“新蛋白时代行业研讨会”系列活动。
谷孚深信发酵技术可以充分发掘微生物的潜能，打破依靠“传统农作物和畜禽资源”获取热量和蛋白的格局。近两年的时间里，谷孚团队访谈了国内外三十余位新蛋白行业的专家和学者，从商业、投资和科研等三大角度，以六个章节梳理了整个新蛋白发酵行业的发展逻辑和宝贵案例，总结了新蛋白发酵产业各个环节的机遇点。报告中首次公开了我国新蛋白发酵企业，以及学术科研机构信息概览，同时深入分析了影响行业发展的因素，包含监管法规和规模化生产等。
The English version of the report summarizes the key players and projections for China’s fermentation protein sector.
行业报告下载 Industry Resources
战略咨询 Strategic consultancy
对于寻求将新蛋白产品推向中国市场或将其融入战略愿景的企业，我们提供不同的工具和建议。We provide different tools and suggestions for companies seeking to introduce emerging alternative protein products to China or integrate them into their strategies.
初创
Startup
企业
Enterprise
投资者
Investor
陈锦慧 Viola Chen
创新主管 - 企业及初创对接
Innovation Specialist - Corporate & Start-up Engagement
谷孚掌握最具影响力和潜力的投资、研究和市场方向，如生物发酵技术及海鲜替代产品。我们认为中国很快将成为下一个替代蛋白创新集群的“热图”。
GFIC has access to the most influential and the latest potential investment, research and market directions in the alt protein field, such as fermentation technology and seafood substitute products. We also provides overseas players with reliable information about the Chinese market to help formulate market entry strategies.
